Accéder au contenu
Merck

A simple protocol to produce mature human-induced pluripotent stem cell-derived cardiomyocytes.

STAR protocols (2021-11-11)
Walter E Knight, Yingqiong Cao, Phoebe Dillon, Kunhua Song
RÉSUMÉ

When cultured under typical conditions, human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are structurally and functionally immature. We have previously demonstrated that culture of hiPSC-CMs in maturation medium containing fatty acids, in combination with culture on micropatterned surfaces, produces cells that demonstrate a more mature phenotype compared to standard approaches. Here, we show in detail the steps needed to produce mature hiPSC-CMs. Compared with many approaches, our protocol is relatively simple and can be easily adapted to new laboratories. For complete details on the use and execution of this protocol, please refer to Knight et al. (2021).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Cocktail d'inhibiteurs de protéases, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
Saccharose, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
MOPS, ≥99.5% (titration)
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Gelatin from porcine skin, gel strength 300, Type A
Sigma-Aldrich
Anticorps monoclonal anti-α-actinine (sarcomérique) antibody produced in mouse, clone EA-53, ascites fluid
Sigma-Aldrich
Hydroxyde de potassium, BioXtra, ≥85% KOH basis
Sigma-Aldrich
Urée, ACS reagent, 99.0-100.5%
Millipore
EDTA, ULTROL® Grade, 500 mM Solution, pH 8.0
Sigma-Aldrich
Acide éthylène glycol-bis(2-aminoéthyléther)-N,N,N′,N′-tétraacétique, ≥97.0%